Stay updated on Pembrolizumab & Romidepsin Combo Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.

Latest updates to the Pembrolizumab & Romidepsin Combo Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.4%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.6%
- Check19 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe webpage has been updated to include new information about recurrent and refractory peripheral T-cell lymphoma treatments, including the addition of a new registry identifier and collaborators, while significant details about the study's objectives and treatment protocols have been removed.SummaryDifference51%
Stay in the know with updates to Pembrolizumab & Romidepsin Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.